Frontlight ResearchEarly access
Trial site
Hopital Purpan
- 7running trials
- 2closed trials
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Multiple sclerosis3 trials
- Psoriasis2 trials
- Psoriatic arthritis2 trials
- Rheumatoid arthritis2 trials
- Alzheimer disease1 trial
- Neuromyelitis optica (NMOSD)1 trial
- Stroke1 trial
- Phase
- Phase 34 trials
- Phase 21 trial
- Status
- Active, not recruiting4 trials
- Recruiting2 trials
- Completed1 trial
- Not yet recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Biogen2 trials
- AbbVie1 trial
- Hoffmann-La Roche1 trial
- Hospices Civils de Lyon1 trial
- Janssen Pharmaceutica N.V., Belgium1 trial
- and 3 more
Running trials
Recruiting
Recruiting
Recruiting
RItuximab Versus Ocrelizumab in Relapsing-remitting Multiple Sclerosis.
Active, not recruiting
Active, not recruiting
Recruiting
French Registry for Monitoring Pregnancies for Multiple Sclerosis
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Multiple sclerosis1 recruiting
- Neuromyelitis optica (NMOSD)1 recruiting
- Rheumatoid arthritis1 recruiting
- Stroke1 recruiting
Closed trials
Completed
Terminated
Site data: ClinicalTrials.govUpdated 18 Nov 2026